Biological test

PreclinicalBiologic

CCentre Oscar Lambret

Biological test is one of 73 biologic programs targeting Breast Cancer. It is currently in Preclinical.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Breast CancerActive, not recruiting

COVID-19Active, not recruiting

MeningitisActive, not recruiting

Breast CancerPreclinical

Active, not recruiting

COVID-19Preclinical

Active, not recruiting

MeningitisPreclinical

Active, not recruiting

Competition

Competitive Landscape

2828 competitors in Breast Cancer

#DrugCompanyPhaseTrials

Avastin

BBio-Thera Solutions

Preclinical

153 2

Nolvadex

SSan Diego Pacific Oncology & Hematology Associates

Preclinical

78 3

Voltaren

Novartis

Preclinical

1 4

Lupron

EEastern Cooperative Oncology Group

Preclinical

5 5

Spravato

WWim Janssens

Preclinical

2 6

Tricor

JJagotec

Preclinical

1 7

Cortef

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Preclinical

1 8

Systemic Therapy

Bristol-Myers Squibb

Preclinical

1 9

Neoadjuvant Therapy

SSun Yat-sen University

Preclinical

3 10

Beta Blocker

WWeill Medical College of Cornell University

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Q1 2028

N/AActive, not recruiting

Breast Cancer

NCT03795246

Clinical

Trials by Indication[1]

Breast Cancer1 trial

Follow-up of Sequential Chemotherapy and Stimulation for Fertility Preservation in Young Patients With Breast Cancer

Active, not recruiting·CCentre Oscar Lambret·N/A·NCT03795246·132 enrolled

Meningitis1 trial

Feasibility of Exosome Analysis in Cerebrospinal Fluid During the Diagnostic Workup of Metastatic Meningitis

Completed·CCentre Oscar Lambret·N/A·NCT05286684·7 enrolled

COVID-191 trial

Collection of Biological Samples With Clinical Characterization of Covid-19 Patients

Terminated·—·N/A·NCT04363385·500 enrolled

Sources

References

[1]
ClinicalTrials.gov — 3 trial records for Biological test. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Biological test compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Biological test. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Centre Oscar Lambret company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Preclinical[1]
Company: CCentre Oscar Lambret

Biological test

Status by Indication[3][1]

Competitive Landscape

Expected Milestones

Q1 2028

Trials by Indication[1]

Breast Cancer1 trial

Meningitis1 trial

COVID-191 trial

References

Drug Info

Quick Facts

Related News